Student awards need a saviour
09 July, 2013The annual Student Excellence Awards, which support Australian students in bioscience research with reward and recognition, are in need of an industry sponsor if they are to go ahead this year.
iSonea raises $13.5m to fund AirSonea launch
09 July, 2013 by Dylan Bushell-EmblingiSonea (ASX:ISN) has raised $13.5m in a placement to help pay the manufacturing, distribution and marketing costs of the upcoming launch of mobile wheeze-monitoring device AirSonea.
Supporting industry innovation
09 July, 2013The $70,000 Australian Innovation Challenge awards are now open and seeking great ideas from Australians.
Bioniche closes funding, licensing deal with Paladin
08 July, 2013 by Dylan Bushell-EmblingBioniche (ASX:BNC) has gained access to a further C$5m in funding after closing its debt refinancing and Urocidin licensing deal with Paladin Labs.
Novogen gets up to $5m to fund CS-6 development
08 July, 2013 by Dylan Bushell-EmblingNovogen (ASX:NRT) has signed a deal with a US investor that will give it access to up to $5m in working capital to help take cancer drug candidate CS-6 into the clinic.
Pharmaxis, Phylogica and LBT win ARC grants
05 July, 2013 by Dylan Bushell-EmblingPharmaxis (ASX:PXS), Phylogica (ASX:PYC) and LBT Innovation (ASX:LBT) will all receive Australian Research Council linkage grants for projects with universities.
Review of employee share schemes announced
04 July, 2013AusBiotech was pleased to learn that the government has announced it will review the policy settings around employee share schemes (ESS).
pSivida initiates posterior uveitis trial
04 July, 2013 by Dylan Bushell-EmblingpSivida (ASX:PVA) has commenced recruitment for one of two planned US phase III trials of its injectable micro-insert in posterior uveitis.
CSL progresses therapies for haemophilia
04 July, 2013A new group of therapies is showing promise for the treatment of haemophilia.
AusBiotech wins grant to engage in Asia
02 July, 2013AusBiotech was among the 27 member-based business organisations that have been awarded grants to help them expand their networks in Asia. The grants were provided under the Australian Government’s inaugural Asian Century Business Engagement plan and announced by the Hon Kelvin Thomson, Parliamentary Secretary for Trade, last Friday.
Phosphagenics investigation
02 July, 2013An independent financial investigation is underway at Phosphagenics.
Carr returns to industry portfolio
02 July, 2013Kevin Rudd’s new cabinet, sworn in yesterday, will see Kim Carr return to take up the industry and innovation and higher education portfolio.
Phylogica advances collaboration with Janssen
02 July, 2013 by Dylan Bushell-EmblingPhylogica (ASX:PYC) has identified peptide candidates in its drug-discovery collaboration with Janssen Biotech and will move on to exploring their functionality within cells.
REVA Medical recruiting in A/NZ for stent trial
01 July, 2013 by Dylan Bushell-EmblingREVA Medical (ASX:RVA) has commenced recruitment for the Australia/New Zealand arm of its CE Mark trial for ReZolve 2, a bioresorbable cardiac scaffold.
Phylogica enhances peptide screening capabilities
28 June, 2013 by Dylan Bushell-EmblingPhylogica (ASX:PYC) has improved its Phylomer peptide screening platform to allow it to discover candidates that can penetrate cell walls and deliver drug cargoes to a specific target.
